Stephen L. Sabba, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 2,000 shares at $207.87 ($416K) on 2026-03-23, disclosed to the SEC on 2026-03-25.
Open-market sale of $416k LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $207.87 | 1,000 | $208K | 50.0% |
| 2 | $207.87 | 1,000 | $208K | 50.0% |
| Total | $207.87 avg | 2,000 | $416K | 100% |
| Filing → |
| LGND | SELL | 2024-03-07 | $281K | — | Filing → |
| LGND | SELL | 2023-05-12 | $988K | — | Filing → |
| LGND | SELL | 2021-02-11 | $6.0M | — | Filing → |